South Korea Biotechnology Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     South Korea 
Biotechnology Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  t he  la tes t  repo r t  by  IMARC G roup ,  t i t l ed  "South  Korea 
B io techno logy  Market :  I ndust ry  Trends ,  Share ,  S i ze ,  Growth ,  Oppor tun i ty  
and  Forecast  2024-2032 ,"  t he  Sout h  Korea  b io techno logy  marke t  s i ze  i s  
p ro jec ted  to  exh ib i t  a  g rowth  ra t e  (CAGR)  o f  XX% dur ing  2024-2032 .
Report The  Sou th  Korea  b io techno logy  marke t  i s  d r i ven  by  the  inc reas ing  p reva lence o f  
va r i ous  l i f es t y l e - re la ted  d isorde rs ,  l i ke  obes i t y ,  d iabe tes ,  hyper t ens ion ,  and  
Highlight and COPD,  ac ross  the  count r y .  Moreover ,  t he  g rowing  ger ia t r i c  popu la t i on ,  who  are  
more  p rone  t o  deve lop ing  ch ron ic  a i lmen ts ,  i s  a l so  augment i ng  t he  demand f o r  
advanced  hea l t hcare  so lu t i ons ,  t hereby  bo ls te r ing  t he  marke t  g rowth .  
Description Add i t i ona l l y ,  t he  gove rnment  au tho r i t i es  in  Sou th  Korea  are  launch ing  i n i t i a t i ves  
to  acce le ra t e  innovat ion  and  co l l abo ra t ion  am ong academia ,  indus t ry  p laye rs ,  and  
governmen t  en t i t i es ,  wh i ch  i s  c rea t i ng  a  pos i t i ve  ou t l ook  fo r  t he  marke t .
Request  fo r  a  PDF  sample  o f  th i s  repor t :  
ht tps : / / www. imarcgroup .com/sout h-korea -b io techno logy-marke t / reques t samp le
Report Description
South  Korea  Biotechnology Market  Trends:
Bes ides  th is ,  the emerg ing p re fe rence fo r  persona l ized  medic ine and  regenerat i ve  therap ies  i s  fu r ther  
prope l l ing  the growth  o f  the  South  Kore  b io technology  market .  Moreover ,  severa l  key  b io tech  f i rms  are  
in tegra t ing AI  and b ig  da ta  ana ly t i cs  in  b io tech  research  to  enhance  drug  d iscovery  p rocesses and c l in ica l  
t r ia ls ,  wh ich  is  ac t ing  as  ano ther  s ign i f i can t  g rowth- induc ing  fac to r .  
Apar t  f rom th is ,  the  esca la t ing  adopt ion  o f  CRISPR-Cas9 and  o ther  gene-ed i t ing  technolog ies ,  wh ich he lp  in  
cor rec t ing genet ic  de fec ts ,  improv ing crop res i l ience  in  agr icu l tu ra l  b io tech,  and  deve lop ing  nove l  therap ies  
fo r  a  range o f  d iseases,  i s  a lso  s t imu la t ing  the  marke t  growth .  Fur thermore ,  co l labora t ions between 
pharmaceut ica l  companies ,  b io tech o rgan izat ions,  and  hea l thcare  p ro fess iona ls  to  fac i l i ta te  the  easy  
ava i lab i l i ty  o f  advanced medicat ions and t rea tments  are  an t ic ipated to  d r ive  the  g rowth  o f  the  South  Korea  
b io technology market  in  the coming years .
View Report  TOC,  F igures and Tables :  h t tps: / /www. imarcgroup.com/south-korea-b iotechnology-market
Product Type Insights:
• Instruments
• Reagents
• Software and Services
 
Technology Insights:
Report • Nanobiotechnology
• Tissue Engineer ing and Regenerat ion
Segmentation
• DNA Sequencing
• Cel l-Based Assays
• Fermentat ion
• PCR Technology
• Chromatography
• Others
Application Insights:
• Healthcare
• Food and Agriculture
• Natural  Resources and Environment
• Industria l  Processing
Report • Bioinformatics
• Others
Segmentation
Regional Insights:
• Seoul Capital  Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central  Region)
• Others
How has the South Korea biotechnology market 
performed so far and how will it perform in the coming 
years?
What has been the impact of COVID-19 on the South 
Korea biotechnology market?
What is the breakup of the South Korea biotechnology 
market on the basis of product type?
Key 
What is the breakup of the South Korea biotechnology 
market on the basis of technology?
Questions 
What is the breakup of the South Korea biotechnology 
Answered in market on the basis of application?
the Report What are the various stages in the value chain of the 
South Korea biotechnology market?
What are the key driving factors and challenges in the 
South Korea biotechnology?
What is the structure of the South Korea biotechnology 
market and who are the key players?
What is the degree of competition in the South Korea 
biotechnology market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    S o u t h  K o r e a  B i o t e c h n o l o g y  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    S o u t h  K o r e a  B i o t e c h n o l o g y  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
6    S o u t h  K o r e a  B i o t e c h n o l o g y  M a r k e t  -  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     I n s t r u m e n t s
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    6 . 2     R e a g e n t s
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
       
    6 . 3     S o f t w a r e  a n d  S e r v i c e s
        6 . 3 . 1  O v e r v i e w
        6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
7    S o u t h  K o r e a  B i o t e c h n o l o g y  M a r k e t  -  B r e a k u p  b y  T e c h n o l o g y
    7 . 1     N a n o b i o t e c h n o l o g y
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 2     T i s s u e  E n g i n e e r i n g  a n d  R e g e n e r a t i o n
        7 . 2 . 1  O v e r v i e w
Table of         7 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        7 . 2 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 3     D N A  S e q u e n c i n g
        7 . 3 . 1  O v e r v i e w
Contents         7 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        7 . 3 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 4     C e l l - B a s e d  A s s a y s
        7 . 4 . 1  O v e r v i e w
        7 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 4 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )
    7 . 5     F e r m e n t a t i o n
        7 . 5 . 1  O v e r v i e w
        7 . 5 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 5 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )   
    7 . 6     P C R  T e c h n o l o g y
        7 . 6 . 1  O v e r v i e w
        7 . 6 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 6 . 3  M a r k e t  F o r e c a s t  (  2 0 2 4 - 2 0 3 2 )   
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /s o u t h -ko rea -b i o tec hn o lo gy -ma rk
e t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: